Fig. 1 · Structure
Documents & Downloads
Soretolide
Antiepileptic Agent
Soretolide is an antiepileptic agent primarily targeting seizure activity. It has demonstrated efficacy in the maximal electroshock-induced seizure (MES) test in rodent models, indicating its potential for seizure management. Additionally, Soretolide inhibits the metabolism of Phenytoin, enhancing its therapeutic effects. The compound exhibits favorable pharmacokinetic properties in rat models, making it a valuable tool for research into antiepileptic therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 130403-08-6 |
| Applications | Antiepileptic Agent |
| Formula | C13H14N2O2 |
| Molecular Weight | 230.26 |
| SMILES | CC1=CC(NC(C2=C(C)C=CC=C2C)=O)=NO1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.